Daniel Murawski, MD
Foot and Ankle Surgery · Gulf Breeze, FLNPI 1033121140
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by CGG Medical Inc at 40.0% of the total. Reporting peaked in 2024 at $1,919 and has fallen 71.1% since, to $555 in 2025.
Across 73 payments — averaging $66.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CGG Medical Inc$2K
- Arthrex$1K
- Stryker$545
- Bioventus LLC$315
- Smith+Nephew$302
- DJO, LLC$226
- plus $476 from 10 others
Across 3 payments — averaging $8796.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$26K
What the payments were for
- Travel & lodging$1,33927%
- Food & beverage$2,34448%
- Education$1,20025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CGG Medical Inc | 7 | $1,954 |
| Arthrex | 14 | $1,064 |
| Stryker(2 entities) | 11 | $545 |
| Bioventus LLC | 9 | $315 |
| Smith+Nephew | 5 | $302 |
| DJO, LLC | 9 | $226 |
| Johnson & Johnson | 7 | $176 |
| Organogenesis Inc. | 1 | $88 |
| Paragon 28, Inc. | 1 | $59 |
| Vericel Corporation | 2 | $46 |
| Aroa Biosurgery Incorporated | 1 | $30 |
| Axogen | 1 | $22 |
| Stimwave Technologies Incorporated | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 2 | $10 |
| Fidia Pharma USA Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$170
- Q-FIX$118
How this compares
$4,883 in reported general payments places this provider in the 55th percentile of 850 foot and ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 34 | $768 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $605 |
| Ondansetron Hcl | 47 | $314 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $182 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Gulf Breeze
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.